WAVE Life Sciences Ltd (WVE)
6.18
+0.01
(+0.16%)
USD |
NASDAQ |
May 31, 16:00
6.175
0.00 (0.00%)
After-Hours: 20:00
WAVE Life Sciences Revenue (Quarterly): 12.54M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 12.54M |
| December 31, 2023 | 29.06M |
| September 30, 2023 | 49.21M |
| June 30, 2023 | 22.11M |
| March 31, 2023 | 12.93M |
| December 31, 2022 | 1.239M |
| September 30, 2022 | 0.285M |
| June 30, 2022 | 0.375M |
| March 31, 2022 | 1.75M |
| December 31, 2021 | 1.765M |
| September 30, 2021 | 36.42M |
| June 30, 2021 | 2.776M |
| March 31, 2021 | |
| December 31, 2020 | 9.439M |
| September 30, 2020 | 3.45M |
| June 30, 2020 | 3.027M |
| March 31, 2020 | 4.161M |
| December 31, 2019 | 2.40M |
| September 30, 2019 | 2.929M |
| Date | Value |
|---|---|
| June 30, 2019 | 7.628M |
| March 31, 2019 | 3.026M |
| December 31, 2018 | 3.62M |
| September 30, 2018 | 4.493M |
| June 30, 2018 | 4.879M |
| March 31, 2018 | 1.422M |
| December 31, 2017 | 1.098M |
| September 30, 2017 | 1.315M |
| June 30, 2017 | 1.097M |
| March 31, 2017 | 0.383M |
| December 31, 2016 | 0.283M |
| September 30, 2016 | 0.392M |
| June 30, 2016 | 0.417M |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | 0.126M |
| March 31, 2015 | 0.026M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.285M
Minimum
Sep 2022
49.21M
Maximum
Sep 2023
10.71M
Average
3.45M
Median
Sep 2020
Revenue (Quarterly) Benchmarks
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -31.56M |
| Total Expenses (Quarterly) | 47.00M |
| EPS Diluted (Quarterly) | -0.24 |
| Enterprise Value | 575.88M |
| Profit Margin (Quarterly) | -251.7% |
| Earnings Yield | -8.41% |
| Normalized Earnings Yield | -9.592 |